Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat.
abdominal obesity
caloric restriction
energy balance
exercise
non-alcoholic fatty liver disease
physical activity
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
25 Mar 2020
25 Mar 2020
Historique:
received:
18
02
2020
revised:
14
03
2020
accepted:
17
03
2020
entrez:
29
3
2020
pubmed:
29
3
2020
medline:
16
12
2020
Statut:
epublish
Résumé
The indisputable association between visceral adipose tissue (VAT) and cardiometabolic risk makes it a primary target for lifestyle-based strategies designed to prevent or manage health risk. Substantive evidence also confirms that liver fat (LF) is positively associated with increased health risk and that reduction is associated with an improved metabolic profile. The independent associations between reductions in VAT, LF, and cardiometabolic risk is less clear. In this narrative review, we summarize the evidence indicating whether a negative energy balance induced by either an increase in energy expenditure (aerobic exercise) or a decrease in energy intake (hypocaloric diet) are effective strategies for reducing both VAT and LF. Consideration will be given to whether a dose-response relationship exists between the negative energy balance induced by exercise or diet and reduction in either VAT or LF. We conclude with recommendations that will help fill gaps in knowledge with respect to lifestyle-based strategies designed to reduce VAT and LF.
Identifiants
pubmed: 32218121
pii: nu12040891
doi: 10.3390/nu12040891
pmc: PMC7230996
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
AJR Am J Roentgenol. 2017 Jan;208(1):92-100
pubmed: 27726414
Prog Cardiovasc Dis. 2015 Jan-Feb;57(4):387-95
pubmed: 25446555
J Appl Physiol (1985). 2004 Sep;97(3):948-54
pubmed: 15121737
Evid Based Complement Alternat Med. 2013;2013:760804
pubmed: 23573151
Br J Radiol. 2012 Jan;85(1009):1-10
pubmed: 21937614
JAMA Intern Med. 2016 Aug 1;176(8):1074-82
pubmed: 27379904
Int J Obes (Lond). 2007 Dec;31(12):1786-97
pubmed: 17637702
PLoS One. 2015 Mar 17;10(3):e0120443
pubmed: 25781622
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1201-4
pubmed: 23353640
J Clin Transl Hepatol. 2018 Jun 28;6(2):217-221
pubmed: 29951367
Hepatology. 2012 Jun;55(6):1738-45
pubmed: 22213436
Nat Rev Endocrinol. 2020 Mar;16(3):177-189
pubmed: 32020062
Liver Int. 2015 Mar;35(3):944-52
pubmed: 24684289
J Appl Physiol (1985). 2005 Oct;99(4):1613-8
pubmed: 16002776
Obes Res. 2004 May;12(5):789-98
pubmed: 15166299
Metabolism. 2017 Mar;68:119-132
pubmed: 28183444
Med Sci Sports Exerc. 2008 Nov;40(11):1863-72
pubmed: 18845966
BMJ Open. 2019 Mar 30;9(3):e026854
pubmed: 30928957
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1596-1603.e3
pubmed: 28501537
Obes Surg. 2006 Jun;16(6):697-701
pubmed: 16756727
Therap Adv Gastroenterol. 2017 Sep;10(9):701-713
pubmed: 28932271
J Diabetes Res. 2017;2017:5071740
pubmed: 28116314
Med Sci Sports Exerc. 2019 Feb 15;:
pubmed: 30789437
Diabetologia. 2011 Oct;54(10):2506-14
pubmed: 21656330
J Hepatol. 2012 Jan;56(1):255-66
pubmed: 21723839
PLoS One. 2013;8(2):e56415
pubmed: 23409182
World J Gastroenterol. 2016 Mar 14;22(10):3023-30
pubmed: 26973398
World J Gastroenterol. 2014 Aug 21;20(31):10851-63
pubmed: 25152587
J Phys Act Health. 2016 Jun;13(6):671-94
pubmed: 26694194
Diabetes Obes Metab. 2018 May;20(5):1131-1139
pubmed: 29272072
World J Gastroenterol. 2016 Jul 21;22(27):6318-27
pubmed: 27468220
Gut. 2009 Sep;58(9):1281-8
pubmed: 19074179
Aliment Pharmacol Ther. 2012 Oct;36(8):772-81
pubmed: 22958053
Obesity (Silver Spring). 2018 Nov;26(11):1696-1703
pubmed: 30261125
Med Sci Sports Exerc. 2017 Sep;49(9):1834-1841
pubmed: 28398943
Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469
pubmed: 21206486
Annu Rev Nutr. 1997;17:527-58
pubmed: 9240939
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725
pubmed: 31301983
Br J Sports Med. 2019 Sep;53(18):1141-1153
pubmed: 30862704
World J Hepatol. 2015 Aug 8;7(16):2041-52
pubmed: 26261693
Eur Radiol. 2011 Jan;21(1):87-97
pubmed: 20680289
Diabetes. 2003 Mar;52(3):701-7
pubmed: 12606511
J Hepatol. 2017 Jan;66(1):142-152
pubmed: 27639843
BMC Gastroenterol. 2006 Nov 02;6:33
pubmed: 17081293
J Hepatol. 2012 Jul;57(1):157-66
pubmed: 22414768
Medicine (Baltimore). 2019 Mar;98(12):e14918
pubmed: 30896648
Hormones (Athens). 2018 Mar;17(1):69-81
pubmed: 29858854
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5
pubmed: 19706383
Clin Sci (Lond). 2015 Dec;129(12):1097-105
pubmed: 26265792
N Engl J Med. 2010 Sep 30;363(14):1341-50
pubmed: 20879883
Ann Intern Med. 2000 Jul 18;133(2):92-103
pubmed: 10896648
Circulation. 2018 Mar 13;137(11):1143-1157
pubmed: 29142011
J Hepatol. 2015 Jul;63(1):174-82
pubmed: 25863524
J Appl Physiol (1985). 1996 Dec;81(6):2445-55
pubmed: 9018491
Obes Rev. 2008 Jul;9(4):312-25
pubmed: 17956544
Obes Rev. 2016 Aug;17(8):664-90
pubmed: 27213481